$BHC
Bausch Health Companies Inc. Stock $bhc

$bhc Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000088559014000063 Filed on August 01, 2014

Income Statement

Concept	2014 Q2	2013 Q2	2013 Q1
Revenue	$2.041B	$1.096B	$1.068B
YoY Change	86.28%	33.61%	24.8%
Cost Of Revenue	$569.6M	$283.2M	$284.9M
YoY Change	101.13%	46.79%	27.08%
Gross Profit	$1.472B	$812.5M	$783.5M
YoY Change	81.11%	29.55%	23.99%
Gross Profit Margin	72.09%	74.15%	73.33%
Selling, General & Admin	$515.7M	$257.3M	$241.9M
YoY Change	100.43%	38.75%	36.45%
% of Gross Profit	35.05%	31.67%	30.87%
Research & Development	$66.50M	$24.50M	$23.80M
YoY Change	171.43%	38.33%	8.15%
% of Gross Profit	4.52%	3.02%	3.04%
Depreciation & Amortization	$407.7M	$317.9M	$341.4M
YoY Change	28.25%	43.33%	58.35%
% of Gross Profit	27.71%	39.13%	43.57%
Operating Expenses	$582.2M	$281.8M	$265.7M
YoY Change	106.6%	38.71%	33.32%
Operating Profit	$355.1M	$141.5M	$117.0M
YoY Change	150.95%	63.0%	90.26%
Interest Expense	-$234.1M	-$181.9M	-$150.4M
YoY Change	28.7%	75.07%	101.88%
% of Operating Profit	-65.93%	-128.55%	-128.55%
Other Income/Expense, Net
YoY Change
Pretax Income	$121.0M	-$40.40M	-$54.80M
YoY Change	-399.5%	136.85%	315.75%
Income Tax	-$1.000M	-$51.20M	-$27.30M
% Of Pretax Income	-0.83%
Net Earnings	$122.0M	$10.80M	-$27.50M
YoY Change	1029.63%	-95.34%	-115.39%
Net Earnings / Revenue	5.98%	0.99%	-2.57%
Basic Earnings Per Share	$0.38	$0.04
Diluted Earnings Per Share	$0.37	$0.03	-$89.93K
COMMON SHARES
Basic Shares Outstanding	335.3M shares	308.1M shares	305.8M shares
Diluted Shares Outstanding	341.3M shares	314.4M shares	305.8M shares

Balance Sheet

Concept	2014 Q2	2013 Q2	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$531.0M	$2.539B	$414.0M
YoY Change	-79.09%	542.78%	24.7%
Cash & Equivalents	$531.2M	$2.539B	$413.7M
Short-Term Investments
Other Short-Term Assets	$1.920B	$368.0M	$393.0M
YoY Change	421.74%	56.6%	84.51%
Inventory	$942.5M	$497.1M	$509.7M
Prepaid Expenses
Receivables	$1.771B	$1.127B	$1.054B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.164B	$4.532B	$2.370B
YoY Change	13.94%	178.04%	54.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.320B	$441.0M	$453.0M
YoY Change	199.23%	7.82%	6.08%
Goodwill	$9.436B	$5.278B	$5.165B
YoY Change	78.79%
Intangibles	$11.75B	$9.290B	$9.227B
YoY Change	26.5%
Long-Term Investments
YoY Change
Other Assets	$206.3M	$199.4M	$180.4M
YoY Change	3.44%	48.83%	47.88%
Total Long-Term Assets	$22.73B	$15.25B	$15.12B
YoY Change	49.06%	23.09%	25.05%
TOTAL ASSETS
Total Short-Term Assets	$5.164B	$4.532B	$2.370B
Total Long-Term Assets	$22.73B	$15.25B	$15.12B
Total Assets	$27.90B	$19.78B	$17.49B
YoY Change	41.01%	41.1%	28.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$327.7M	$284.5M	$183.0M
YoY Change	15.17%	82.4%	17.32%
Accrued Expenses	$1.775B	$1.035B	$1.072B
YoY Change	71.49%	72.21%	97.35%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$266.7M	$346.9M	$289.7M
YoY Change	-23.11%	77.88%	99.78%
Total Short-Term Liabilities	$2.496B	$1.762B	$1.646B
YoY Change	41.69%	67.95%	71.83%
LONG-TERM LIABILITIES
Long-Term Debt	$17.06B	$10.45B	$10.33B
YoY Change	63.29%	42.02%	50.74%
Other Long-Term Liabilities	$215.0M	$161.7M	$167.1M
YoY Change	32.95%	-76.56%	-72.15%
Total Long-Term Liabilities	$17.27B	$10.61B	$10.49B
YoY Change	62.82%	31.85%	40.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.496B	$1.762B	$1.646B
Total Long-Term Liabilities	$17.27B	$10.61B	$10.49B
Total Liabilities	$22.53B	$14.08B	$13.90B
YoY Change	60.01%	36.38%	45.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.175B	-$2.429B	-$2.424B
YoY Change	30.72%
Common Stock	$8.538B	$8.475B	$6.208B
YoY Change	0.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.258B	$5.703B	$3.587B
YoY Change
Total Liabilities & Shareholders Equity	$27.90B	$19.78B	$17.49B
YoY Change	41.01%	41.1%	28.39%

Cashflow Statement

Concept	2014 Q2	2013 Q2	2013 Q1
OPERATING ACTIVITIES
Net Income	$122.0M	$10.80M	-$27.50M
YoY Change	1029.63%	-95.34%	-115.39%
Depreciation, Depletion And Amortization	$407.7M	$317.9M	$341.4M
YoY Change	28.25%	43.33%	58.35%
Cash From Operating Activities	$376.0M	$305.1M	$255.3M
YoY Change	23.24%	19.84%	52.69%
INVESTING ACTIVITIES
Capital Expenditures	$113.5M	$12.80M	$14.00M
YoY Change	786.72%	-5.89%	25.94%
Acquisitions	$68.00M	$513.4M	$237.6M
YoY Change	-86.75%	13.08%	-12.91%
Other Investing Activities	-$1.400M	-$486.4M	-$220.2M
YoY Change	-99.71%	5.33%	7.21%
Cash From Investing Activities	-$266.4M	-$531.7M	-$234.9M
YoY Change	-49.9%	11.68%	7.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	-$2.251B	$35.00M
YoY Change	-100.0%	-1408.49%	-67.81%
Debt Paid & Issued, Net	$120.3M	$174.7M	$430.0M
YoY Change	-31.14%	37.36%	42.0%
Cash From Financing Activities	-$156.6M	2.356B	-515.9M
YoY Change	-106.65%	705.5%	-345.2%
NET CHANGE
Cash From Operating Activities	$376.0M	305.1M	255.3M
Cash From Investing Activities	-$266.4M	-531.7M	-234.9M
Cash From Financing Activities	-$156.6M	2.356B	-515.9M
Net Change In Cash	-$47.00M	2.130B	-495.5M
YoY Change	-102.21%	2899.3%	-411.24%
FREE CASH FLOW
Cash From Operating Activities	$376.0M	$305.1M	$255.3M
Capital Expenditures	$113.5M	$12.80M	$14.00M
Free Cash Flow	$262.5M	$292.3M	$241.3M
YoY Change	-10.2%	21.29%	54.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.31
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16500000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15600000	USD
	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-36500000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16500000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-104700000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-132800000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-119400000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-343900000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	228800000	USD
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	212200000	USD
	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-21500000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	40400000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	16400000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	1200000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	327000000	USD
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	327700000	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1774900000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1800200000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7400000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	40400000	USD
CY2014Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11300000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	23500000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	42900000	USD
CY2013Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	33300000	USD
CY2013Q4	us-gaap	Assets Assets	27970800000	USD
CY2014Q2	us-gaap	Assets Assets	27895600000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	3885900000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	5163700000	USD
CY2013Q4	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	15900000	USD
CY2014Q2	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	1156900000	USD
CY2014Q2	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	4300000	USD
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.31
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.31
CY2013Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.06
CY2014Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.38
CY2014Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.37
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.30
CY2013Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	66000000	USD
CY2013Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.06
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-104200000	USD
CY2014Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	127700000	USD
CY2013Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-21500000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	102500000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3874600000	USD
CY2013Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1957600000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3930900000	USD
CY2014Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2041100000	USD
CY2014Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	600000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2100000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	15800000	USD
CY2013Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	7900000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-1500000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-1900000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-10800000	USD
CY2013Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-3700000	USD
CY2013Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	114500000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	88900000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	531200000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	600300000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2539400000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	916100000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	413700000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	576300000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2014Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	333036637	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	333777181	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	333036637	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	333777181	shares
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	8325900000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	8301200000	USD
	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform with the current year presentation.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div>
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-241200000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	161100000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-136300000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	131300000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4700000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3200000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-241200000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	128100000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-136300000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	156400000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1073700000	USD
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	569600000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	568100000	USD
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	283200000	USD
CY2013Q2	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	14500000	USD
CY2014Q2	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	16000000	USD
	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	29900000	USD
	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	30300000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1905600000	USD
CY2013Q2	us-gaap	Costs And Expenses CostsAndExpenses	954200000	USD
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	1686000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	3215600000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	366900000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	309800000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	18300000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	54900000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	477600000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	487200000	USD
CY2014Q2	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	11000000	USD
CY2014Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2238800000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2319200000	USD
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	317900000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	659300000	USD
CY2014Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	407700000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	808800000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2014Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	1900000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	400000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-10700000	USD
CY2013Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-3800000	USD
CY2014Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	16400000	USD
CY2013Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	11800000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1200000	USD
CY2014Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
CY2013Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	11800000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1200000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	16400000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3827400000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4439400000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1412700000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1091900000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1215700000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1275400000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1366600000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14172200000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14398800000	USD
CY2014Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9732800000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10571400000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-8600000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10000000	USD
CY2013Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10000000	USD
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3400000	USD
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	5300000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-7300000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	1000000	USD
	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	8200000	USD
CY2013Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-10600000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-8800000	USD
	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	2900000	USD
CY2014Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	2500000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	2500000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	5800000	USD
CY2013Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	3900000	USD
CY2014Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1500000	USD
CY2013Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1100000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	47300000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-5600000	USD
CY2013Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-21400000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-93700000	USD
CY2014Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-93700000	USD
CY2014Q2	us-gaap	Goodwill Goodwill	9436300000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	9752100000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	111700000	USD
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-15300000	USD
	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	16700000	USD
	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	428900000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	125800000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-40400000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	121000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-95200000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-78500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24100000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-51200000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-124900000	USD
CY2013Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	47400000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-72300000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	56600000	USD
CY2013Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	49300000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	83800000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	161000000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	53700000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	58900000	USD
CY2013Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	34000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	81300000	USD
CY2014Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12100000	USD
CY2014Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-24800000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-32200000	USD
CY2013Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9900000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-29000000	USD
CY2013Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	16675600000	USD
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6000000	shares
CY2013Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6300000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6300000	shares
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	410600000	USD
CY2014Q2	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	900000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	14500000	USD
CY2014Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	16190800000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12848200000	USD
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11751400000	USD
CY2013Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	176800000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	487700000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	332100000	USD
CY2014Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	241200000	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	656300000	USD
CY2014Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	709500000	USD
CY2013Q4	us-gaap	Inventory Gross InventoryGross	982800000	USD
CY2014Q2	us-gaap	Inventory Gross InventoryGross	1057000000	USD
CY2014Q2	us-gaap	Inventory Net InventoryNet	942500000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	883000000	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	221800000	USD
CY2014Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	236600000	USD
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	99800000	USD
CY2014Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	114500000	USD
CY2014Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	110900000	USD
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	104700000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000000	USD
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1200000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2600000	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	22737500000	USD
CY2014Q2	us-gaap	Liabilities Liabilities	22528300000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27970800000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27895600000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2496300000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2512500000	USD
CY2013Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2014Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	27100000	USD
CY2013Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	169100000	USD
CY2014Q2	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	115800000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	17367700000	USD
CY2014Q2	us-gaap	Long Term Debt LongTermDebt	17325500000	USD
CY2014Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	266700000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	204800000	USD
CY2014Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	18200000000	USD
CY2013Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	18400000000	USD
CY2014Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17058800000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17162900000	USD
CY2014Q2	us-gaap	Minority Interest MinorityInterest	109200000	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	114600000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is a multinational, specialty pharmaceutical and medical device company that develops, manufactures, and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical eq</font><font style="font-family:inherit;font-size:10pt;">uipment, and aesthetics devices), which are markete</font><font style="font-family:inherit;font-size:10pt;">d directly or indirectly in over </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> countries. Effective August 9, 2013, the Company continued from the federal jurisdiction of Canada to the Province of British Columbia, meaning that the Company became a company registered under the laws of the Province of British Columbia as if it had been incorporated under the laws of the Province of British Columbia. As a result of this continuance, the legal domicile of the Company became the Province of British Columbia, the Canada Business Corporations Act ceased to apply to the Company and the Company became subject to the British Columbia Business Corporations Act. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2013, the Company acquired Bausch & Lomb Holdings Incorporated (“B&L”), pursuant to an Agreement and Plan of Merger, as amended (the “Merger Agreement”) dated May 24, 2013, with B&L surviving as a wholly-owned subsidiary of Valeant Pharmaceuticals International (“Valeant”), a wholly-owned subsidiary of the Company (the “B&L Acquisition”). </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For further information regarding the B&L Acquisition, see note 3 titled “BUSINESS COMBINATIONS”.</font></div></div>
CY2014Q2	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-45100000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	1623300000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	2125700000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-69100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-279300000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2356100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1840200000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-156600000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-650500000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-531700000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-766600000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-266400000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	376000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	860300000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	305100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	560400000	USD
CY2014Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3800000	USD
CY2013Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1500000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10800000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	125800000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	103200000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16700000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	42600000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	4000000	USD
CY2014Q2	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2013Q2	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	5000000	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	3300000	USD
CY2014Q2	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	100	country
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segments
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	355100000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	141500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	711700000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	258500000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	206300000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	195500000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	1200000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	600000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	8100000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-224200000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6400000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	13800000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-141100000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-224200000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-224500000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	26400000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-147100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-224500000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	26400000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	34400000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1200000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-3900000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	18500000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	18500000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Income OtherIncome	5600000	USD
CY2014Q2	us-gaap	Other Income OtherIncome	-400000	USD
	us-gaap	Other Income OtherIncome	-43700000	USD
CY2013Q2	us-gaap	Other Income OtherIncome	1100000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	160500000	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	215000000	USD
CY2013Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7700000	USD
CY2014Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3700000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6100000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	8600000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-5600000	USD
CY2013Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1100000	USD
CY2014Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	400000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	43700000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	61700000	USD
CY2013Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	32200000	USD
CY2014Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	47000000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	82100000	USD
CY2013Q2	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	11700000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	55600000	USD
CY2014Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20600000	USD
CY2014Q2	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	3100000	USD
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	3100000	USD
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	USD
CY2013Q2	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	USD
CY2013Q2	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	300000	USD
CY2014Q2	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	900000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	33600000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	10800000	USD
CY2013Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	30500000	USD
CY2013Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	14700000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	36500000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	21500000	USD
CY2014Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8800000	USD
CY2013Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	513400000	USD
CY2014Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	68000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	374300000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	751000000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	31500000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	33200000	USD
CY2013Q2	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	32500000	USD
CY2014Q2	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10400000	USD
CY2013Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12800000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	171600000	USD
CY2014Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	113500000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26800000	USD
CY2014Q2	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	75900000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	75900000	USD
CY2013Q2	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
CY2014Q2	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2013Q2	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3300000	USD
CY2013Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	172000000	USD
CY2014Q2	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	165500000	USD
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	452600000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	343400000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2271200000	USD
CY2013Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2271200000	USD
CY2014Q2	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	50000000	USD
CY2013Q2	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	340000000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	340000000	USD
CY2014Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1300000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1300000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2800000	USD
CY2013Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	17000000	USD
CY2013Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	8000000	USD
CY2014Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	27400000	USD
CY2014Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1400000	USD
CY2013Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	19000000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	18600000	USD
CY2014Q2	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	4800000	USD
CY2013Q2	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	14100000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	6400000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4600000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7100000	USD
CY2013Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000000	USD
CY2014Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3600000	USD
	us-gaap	Profit Loss ProfitLoss	101700000	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	122000000	USD
	us-gaap	Profit Loss ProfitLoss	-16700000	USD
CY2013Q2	us-gaap	Profit Loss ProfitLoss	10800000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1319600000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1234200000	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1676400000	USD
CY2014Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	1770700000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	554200000	USD
CY2013Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	174700000	USD
CY2014Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	120300000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	604700000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	13200000	USD
CY2013Q2	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	10900000	USD
CY2014Q2	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	8100000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	12300000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	48300000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	127800000	USD
CY2013Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	24500000	USD
CY2014Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	66500000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	400000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	4800000	USD
CY2013Q2	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	4800000	USD
CY2014Q2	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	400000	USD
	us-gaap	Restructuring Charges RestructuringCharges	102600000	USD
	us-gaap	Restructuring Charges RestructuringCharges	275700000	USD
CY2013Q2	us-gaap	Restructuring Charges RestructuringCharges	53600000	USD
CY2014Q2	us-gaap	Restructuring Charges RestructuringCharges	142100000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3175300000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3278500000	USD
	us-gaap	Revenues Revenues	2164100000	USD
	us-gaap	Revenues Revenues	3927300000	USD
CY2013Q2	us-gaap	Revenues Revenues	1095700000	USD
CY2014Q2	us-gaap	Revenues Revenues	2041100000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3845200000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2102400000	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1994100000	USD
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1063500000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	499200000	USD
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	257300000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	515700000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	997700000	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	15600000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16500000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	40400000	USD
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7400000	USD
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	27058824	shares
CY2013Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2300000000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2269500000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1000000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7200000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3100000	USD
CY2013Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	225000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	55600000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	5118700000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	5258100000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5233300000	USD
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5367300000	USD
CY2013Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5702500000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3717400000	USD
CY2014Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	42800000	USD
CY2014Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20400000	USD
CY2014Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	300000	USD
CY2014Q2	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	15900000	USD
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	15900000	USD
CY2014Q2	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	4300000	USD
CY2014Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	118600000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the unaudited consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the dates of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the operating results for the interim periods presented are not necessarily indicative of the results expected for the full year.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s results of operations and financial position could be materially impacted.</font></div></div>
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	314400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	307700000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	341300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	341400000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	307700000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335300000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	308100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335100000	shares
	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	9500000	USD
CY2013Q2	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	26600000	USD
	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	69800000	USD
CY2014Q2	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	4300000	USD
CY2013Q2	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	11600000	USD
CY2014Q2	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	16000000	USD
	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	35600000	USD
	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	20600000	USD
CY2013Q2	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	303600000	USD
CY2014Q2	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	365600000	USD
	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	629800000	USD
	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	720800000	USD
	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	67400000	USD
CY2013Q2	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	8300000	USD
	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	49100000	USD
CY2014Q2	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	27400000	USD
	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	1500000	USD
CY2014Q2	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	1900000	USD
CY2013Q2	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	3700000	USD
	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	10800000	USD
CY2014Q2	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	238100000	USD
CY2013Q4	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	241300000	USD
CY2014Q2	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-21400000	USD
CY2013Q2	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-63200000	USD
	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-100600000	USD
	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-11400000	USD
	vrx	Defined Benefit Plan Employer Contribution Maximum Age DefinedBenefitPlanEmployerContributionMaximumAge	P65Y
	vrx	Highly Liquid Investments Maturity Period HighlyLiquidInvestmentsMaturityPeriod	P3M
CY2014Q2	vrx	Longtermdebt Prepayments Reductionin Principal LongtermdebtPrepaymentsReductioninPrincipal	70300000	USD
CY2014Q2	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	0	USD
	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	3900000	USD
CY2013Q2	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	3900000	USD
	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	0	USD
	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	3600000	USD
	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	2700000	USD
CY2013Q2	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	-2100000	USD
CY2014Q2	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	2700000	USD
CY2013Q2	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	2300000	USD
CY2014Q2	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	7500000	USD
CY2013Q2	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	61800000	USD
	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	82200000	USD
	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	82900000	USD
CY2014Q2	vrx	Payments Of Contingent Consideration PaymentsOfContingentConsideration	72500000	USD
	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	314100000	shares
	vrx	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	4800000	USD
CY2013Q2	vrx	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	4800000	USD
	vrx	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	20400000	USD
CY2014Q2	vrx	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	8400000	USD
CY2013Q2	vrx	Saleof Stock Public Offering Price Per Share SaleofStockPublicOfferingPricePerShare	85.00
CY2013Q2	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	5943700000	USD
CY2014Q2	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	5239200000	USD
CY2014Q2	vrx	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	227800000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000885590
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	335411043	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Valeant Pharmaceuticals International, Inc.

Files In Submission

Name	View Source	Status
0000885590-14-000063-index-headers.html	Edgar Link	pending
0000885590-14-000063-index.html	Edgar Link	pending
0000885590-14-000063.txt	Edgar Link	pending
0000885590-14-000063-xbrl.zip	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
exhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
valeantq22014.htm	Edgar Link	pending
vrx-20140630.xml	Edgar Link	completed
vrx-20140630.xsd	Edgar Link	pending
vrx-20140630_cal.xml	Edgar Link	unprocessable
vrx-20140630_def.xml	Edgar Link	unprocessable
vrx-20140630_lab.xml	Edgar Link	unprocessable
vrx-20140630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHC
Bausch Health Companies Inc. Stock $bhc

2014 Q2 Form 10-Q Financial Statement

#000088559014000063 Filed on August 01, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC Bausch Health Companies Inc. Stock $bhc

2014 Q2 Form 10-Q Financial Statement

#000088559014000063 Filed on August 01, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC
Bausch Health Companies Inc. Stock $bhc